{
    "Trade/Device Name(s)": [
        "Waters Oxicom Control",
        "Oxygen Saturation Control"
    ],
    "Submitter Information": "Bionostics, Inc.",
    "510(k) Number": "K053327",
    "Predicate Device Reference 510(k) Number(s)": [
        "K921519",
        "K974822",
        "K880447"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "January 26, 2006",
    "Summary Letter Received Date": "December 1, 2005",
    "Submission Date": "November 30, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Oxygen saturation (S02%)"
    ],
    "Specimen Type(s)": [
        "Whole Blood (simulated)"
    ],
    "Specimen Container(s)": [
        "Glass bottle"
    ],
    "Instrument(s)/Platform(s)": [
        "Waters Oxicom 2000",
        "Waters Oxicom 2100",
        "Waters Oxicom 3000"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric measurement",
        "Absorbance at dual wavelengths"
    ],
    "Methodologies": [
        "Quality control evaluation",
        "Light absorbance measurement"
    ],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Waters Oxicom Control liquid QC material to monitor oxygen saturation measurement performance of Waters Oxicom meters.",
    "Indications for Use Summary": "Intended to monitor and evaluate analytical performance of Waters Oxicom oxygen saturation meters by providing three levels of oxygen saturation for objective assessment and precision monitoring in laboratory practice.",
    "fda_folder": "Clinical Chemistry"
}